TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $192,000 | -69.9% | 3,251 | -40.7% | 0.00% | -75.0% |
| Q1 2022 | $638,000 | +10.0% | 5,484 | +42.4% | 0.00% | 0.0% |
| Q4 2021 | $580,000 | +28.9% | 3,852 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $450,000 | +21.3% | 3,768 | -1.1% | 0.00% | +33.3% |
| Q2 2021 | $371,000 | -0.5% | 3,811 | -9.8% | 0.00% | -25.0% |
| Q1 2021 | $373,000 | +85.6% | 4,224 | +101.0% | 0.00% | +33.3% |
| Q4 2020 | $201,000 | -15.9% | 2,102 | +0.0% | 0.00% | -25.0% |
| Q3 2020 | $239,000 | +17.7% | 2,101 | +2.5% | 0.00% | +33.3% |
| Q2 2020 | $203,000 | +36.2% | 2,050 | -17.4% | 0.00% | 0.0% |
| Q1 2020 | $149,000 | +119.1% | 2,481 | +114.8% | 0.00% | +50.0% |
| Q3 2019 | $68,000 | +240.0% | 1,155 | +278.7% | 0.00% | +100.0% |
| Q2 2019 | $20,000 | +5.3% | 305 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $19,000 | – | 305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |